Abstract: A system for user and entity behavioral analysis using an advanced cyber decision platform is provided, comprising a grouping engine configured to create an interaction dataset based at least in part on interactions within a particular network, process the interaction to generate an interaction map, and create a plurality of groups based at least in part by the interaction map; a behavioral analysis engine configured to create a network-usage dataset, and process the network-usage dataset to generate a behavioral baseline for each group; and a monitoring service configured to continuously monitor each group for anomalous network behavior.

Abstract: Source tracking for phased array systems is described herein. One processing device includes a transceiver to transmit or receive radio frequency (RF) signals via a plurality of antenna elements and a processor coupled to the transceiver. The processor executes a multi-angle source-tracking tool configured to determine and store a set of angle estimation values of an angle between the plurality of antenna elements and the second antenna, a set of confidence measurements, and at least one of an Area-of-Arrival (ARoA) value or an Area-of-Departure (ARoD) value based on the RF signals. Each of the set of confidence measurements indicates a confidence of an angle estimation value of the set of angle estimation values.

Abstract: The invention encompasses methods of treating a patient with cancer, such as glioblastoma. The methods may include the administration of one or more pharmaceutical compositions that are capable of inhibiting TROY to treat the patient with cancer.

Abstract: The invention encompasses methods of treating a patient with cancer, such as glioblastoma. The methods may include the administration of one or more pharmaceutical compositions that are capable of inhibiting TROY to treat the patient with cancer.

Abstract: The present disclosure is directed to methods of screening a compound for modulating activity at a TNF-like weak inducer of apoptosis (TWEAK) binding site on a cysteine-rich domain (CRD) of fibroblast growth factor-inducible 14 (Fn14). The present disclosure also provides heterocyclic compounds and pharmaceutically acceptable salts thereof and methods for the prevention, treatment, and amelioration of cell proliferative disorders with these compounds.

Abstract: The invention encompasses methods used in the sensitization and treatment of cancer based upon the expression of SGEF.

Abstract: The invention encompasses methods of treating a patient with cancer, such as glioblastoma. The methods may include the administration of one or more pharmaceutical compositions that are capable of inhibiting TROY to treat the patient with cancer.

Abstract: The present disclosure is directed to methods of screening a compound for modulating activity at a TNF-like weak inducer of apoptosis (TWEAK) binding site on a cysteine-rich domain (CRD) of fibroblast growth factor-inducible 14 (Fn14). The present disclosure also provides heterocyclic compounds and pharmaceutically acceptable salts thereof and methods for the prevention, treatment, and amelioration of cell proliferative disorders with these compounds.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of TROY. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.

Abstract: The present disclosure is directed to methods of using fibroblast growth factor-inducible 14 (Fn14) antagonists to modulate activity at a TNF-like weak inducer of apoptosis (TWEAK) binding site on a cysteine-rich domain (CRD) of Fn14. The present disclosure also provides pharmaceutical compositions comprising synergistic combinations Fn14 antagonists and chemotherapeutic agents.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of TROY. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.

Abstract: The present disclosure is directed to methods of using fibroblast growth factor-inducible 14 (Fn14) antagonists to modulate activity at a TNF-like weak inducer of apoptosis (TWEAK) binding site on a cysteine-rich domain (CRD) of Fn14. The present disclosure also provides pharmaceutical compositions comprising synergistic combinations Fn14 antagonists and chemotherapeutic agents.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.

Abstract: The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of TROY. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.

Abstract: An intermediary system that seamlessly evolves the 2G/2.5G storage mediums to the 3G entities (e.g., a logical HSS) and provides subscriber data to 3G services such as IMS, from legacy data sources. An Intermediary Query Manager (IQM) is provided that functions as intermediary/broker system, and supports defined standard 3GPP interfaces specific to the IMS system (utilizing the existing storage medium servicing the PS domain) and also allows the continued support of the 2G/2.5G interfaces to 2G HLRs (servicing the CS domain). The IQM provides the capability to leverage usage of the current subscriber databases without requiring extraordinary efforts to migrate subscriber information to a new dedicated HSS element. The IQM provides data from multiple sources and processes requests necessary to fulfill these requests. The IQM can look like a MSC (Mobile Switching Center), VLR (Visitor Location Register), and/or SCP (Service Control Point) to the HLRs depending on the type of queries.

Abstract: Advice of charge information is provided utilizing the session initiation protocol (SIP) in an Internet protocol multimedia subsystem without utilizing an application server. The advice of charge message is provided to a user via the serving call/session control function and the home subscription server. When a request for a service is received by the serving call/session control function, the state of a binary, Boolean flag associated with the originator of the request is analyzed. Depending upon the state of the flag, either the request is routed to its intended destination, or an advice of charge message is routed to originating user, advising the user of the charge for the requested service. If the user accepts the charge, the serving call/session control function transmits the request for routing to the intended destination, and the flag is toggled. If the user declines the charge, the call is ended.

Abstract: A provided smart switch called Occupant Counter Control Switch, or OCCS, basically comprises of a motion sensor PIR, a photo sensor, an amplifier with band-pass filter, a microprocessor, a digital display, and a relay or triac to drive electrical appliances such as lights. The PIR sensor detects heat from a human body moving across it and generates a distinctive signal that is, unique to each of the two directions, further processed by the microprocessor for counting and thereby controlling the relay. Installed at the entrance of a room replacing the regular switch (see FIG. 1), the OCCS counts up, displaying a digit great than zero, upon detecting a person entering the room and turns on the lights if sensing insufficient ambient light. OCCS constantly energizes the lights during the room is occupied and immediately switches them off upon counting down to zero when detecting the last person exiting the room.